Target intelligence / Profile preview

SNX29 antisense RNA 1 (SNX29-AS1)

Target
SNX29-AS1
Molecular classification
Other (long non-coding RNA, lncRNA)
01

Overview

**SNX29 antisense RNA 1 (SNX29-AS1)** is most likely a presumed or inferred long non-coding RNA (lncRNA) transcribed from the antisense strand relative to the *Sorting nexin 29* (SNX29) gene. However, no authoritative gene or RNA database entries specifically identify "SNX29-AS1." The related genes and RNAs, such as SNX29 (Sorting nexin 29, a protein-coding gene[3][7]) and other lncRNAs with "-AS1" designations, are documented, but "SNX29-AS1" does not appear in major sources such as NCBI Gene, GeneCards, or The Human Protein Atlas for humans or model organisms as of the latest available data. Therefore, this target name is likely incorrect, missing, or only sparsely characterized in the literature. **Explanation and Supporting Details:** - *SNX29* is a well-described protein-coding gene encoding sorting nexin 29, involved in lipid metabolism, vesicular transport, and potentially in reproductive and neurodevelopmental traits[1][3][7]. - “AS1” designations generally indicate a non-coding RNA (lncRNA) antisense to a corresponding protein-coding gene, but “SNX29-AS1” is not documented in standardized databases or research literature as of 2025 in relation to the SNX29 locus. - There is no evidence that “SNX29-AS1” encodes a therapeutic target (receptor, enzyme, transporter, etc.) nor are there any validated drug interactions, disease roles, or associated mechanisms. - Thus, this entry is likely based on a misnomer, speculative annotation, or an uncharacterized transcript, and should be flagged as incorrect or insufficient for structured biological database inclusion.

Beyond the preview

Go deeper on SNX29 antisense RNA 1 (SNX29-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SNX29 antisense RNA 1 (SNX29-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call